Feasibility and Acceptability of Implementing DIALOG+ in a Psychiatric Rehabilitation Unit
Implementing the DIALOG Outcome Measure and a Solution-Focused Intervention (DIALOG+) in a Rehabilitation Psychiatric Inpatient Setting: A Mixed Methods Feasibility Study
1 other identifier
interventional
8
1 country
1
Brief Summary
This study aims to understand if implementing DIALOG+ in an inpatient psychiatric rehabilitation setting is feasible (can the intervention be implemented) and acceptable (how the intervention is perceived by staff and patient participants). If the intervention is proven to be feasible and acceptable a larger-scale study may take place. This study has been developed in response to the trust-wide implementation of DIALOG outcome measures. DIALOG+ offers additional solution-focused and person-centred follow-up questions to the DIALOG questions and links to multidisciplinary team (MDT) discussions. It is hoped that the conversations had during DIALOG+ meetings will support positive outcomes, and the learning gathered from this study will drive change and improvement for other people requiring psychiatric rehabilitation inpatient admissions in the future. DIALOG+ has been successfully implemented in community settings in the national health service (NHS) but has not been implemented in psychiatric rehabilitation inpatient settings. This study will aim to recruit patient and staff participants from NHS psychiatric rehabilitation inpatient wards. Patient participants who will be eligible to take part are those who can consent, are between the ages of 18-65, and can complete DIALOG and DIALOG+. To understand the feasibility of the intervention, descriptive statistics will be collected and to understand acceptability focus groups will take place and surveys will be collected. Quantitative data collection will take place over 5 months and will be split into 2 groups. Group one will be a comparison group where participants will act as an extended baseline group and biweekly DIALOG outcomes will be collected. Group 2 will be a Treatment group and participants will receive the DIALOG+ intervention intervention, DIALOG outcomes will be collected biweekly as part of the intervention. Finally, there will be a period to gather qualitative feedback from patient participants using surveys, and from staff participants using focus groups or semi-structured interviews.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2024
CompletedFirst Posted
Study publicly available on registry
June 26, 2024
CompletedStudy Start
First participant enrolled
October 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 24, 2025
CompletedMarch 13, 2026
May 1, 2024
7 months
May 20, 2024
March 10, 2026
Conditions
Outcome Measures
Primary Outcomes (12)
Feasibility outcome- Recruitment rate/consent rate
The number of people who agreed and consented to participate in the study out of the total number of eligible participants approached. Reported as a percentage.
assessed at the end of the study (after 5 months)
Feasibility outcome- Number of eligible participants.
Eligible participants are those who meet the inclusion criteria, reported as a count of participants.
assessed at the end of the study (after 5 months)
Feasibility outcome- Participation rate
The proportion of those who consented and agreed to engage in DIALOG and DIALOG+ out of the number of participants who engaged in the intervention after consenting. Reported as a percentage of participants.
assessed at the end of the study (after 5 months)
Feasibility outcome- Completion rate
The proportion of those who completed the intervention out of the number who consented and engaged in DIALOG and DIALOG+. Reported as a percentage of participants.
assessed at the end of the study (after 5 months)
Feasibility outcome- Drop out rate
The number of participants who completed the intervention out of total number of patients enrolled. Reported as a percentage of participants.
assessed at the end of the study (after 5 months)
Feasibility outcomes- Reasons for drop out
Reasons for drop out will be assessed when by asking the participant after drop out.
assessed at the end of the study (after 5 months)
Feasibility outcomes- Follow up rate
The number of patients willing to engage in follow-up surveys related to the study out of the total number of participants enrolled in the study. Reported as a percentage of participants.
assessed at the end of the study (after 5 months)
Feasibility outcome- The willingness of clinicians to recruit participants
Number of staff members who attend DIALOG+ training and implement intervention out of the total number of staff offered to participate. Reported as a percentage.
assessed at the end of the study (after 5 months)
Feasibility outcome- Average number of DIALOG+ sessions
Reported as the average number of participants.
assessed at the end of the study (5 months)
Acceptability outcome- Cost
Analysing the cost and benefits of implementing the intervention (including staff training). Reported as a total amount or duration of time spent on training (minutes).
assessed at the end of the study (after 5 months)
Number of staff participants who find DIALOG and DIALOG+ feasible and acceptable to implement in an inpatient rehabilitation setting. Assessed using thematic analysis of focus groups.
To assess the acceptability of the intervention a theoretical framework (Sekhon et al., 2017) was used. Feasibility objectives are defined by Bugge et al., 2013. Focus group transcripts will be subject to a qualitative thematic analysis. Analysis of focus groups will involve coding, organising coding into themes, reviewing themes, and generating a final thematic overview with in relation to the research question (Braun \& Clarke, 2006).
assessed at the end of the study (after 5 months)
Number of patients who find it feasible and acceptable to implement DIALOG and DIALOG+ in an inpatient rehabilitation setting. Assessed using thematic analysis and average scores of patient surveys.
The questionnaires will be a mixture of open ended questions and Likert Scale questions based on questions asked by Matanov et al. (2021), 8 of the questions are scored on a Likert scale (1-5). The survey will be given to patients post-intervention. Questions on the scale have been specifically developed to assess feasibility and acceptability of DIALOG+. An average total score will be used in the analysis of Likert scale questions. Open-ended questionnaire responses will be subject to a qualitative thematic analysis. Analysis will involve coding, organising coding into themes, reviewing themes, and generating a final thematic overview in relation to the research question (Braun \& Clarke, 2006).
assessed at the end of the study (after 5 months)
Secondary Outcomes (3)
DIALOG questionnaire
At the beginning of the study, then biweekly for a duration of 5 months with the final measure taken after 5 months
Demographic information
assessed at the end of the study (5 months)
Length of admission in months
assessed at the end of the study (5 months)
Study Arms (2)
DIALOG
OTHERThis is the comparison group, they will complete the DIALOG measure biweekly for 5 months. DIALOG scores pre and post-intervention will be used in the analyses.
DIALOG+
ACTIVE COMPARATORThis is the treatment group. The participants in this group have agreed to participate in DIALOG+ and will receive the intervention biweekly for 10 sessions (5 months). Pre and post-intervention DIALOG scores will be used in the analysis.
Interventions
An outcome measure consisting of 11 questions, with 8 related to quality of life and 3 items on treatment satisfaction. Patients can rate their satisfaction on a 7-point scale for each of the 8 life domains and 3 treatment aspects, resulting in scores for both quality of life and treatment satisfaction. The DIALOG scale does not provide any guidance for patient and clinician interactions.
Eligibility Criteria
You may qualify if:
- Aged between 18-65
- Capacity to give informed consent as determined by the MDT and through following informed consent processes.
- Admitted into the inpatient ward
- Can complete DIALOG and DIALOG+
You may not qualify if:
- No capacity to consent
- Insufficient command of the English language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Sheffieldlead
- National Health Service, United Kingdomcollaborator
Study Sites (1)
Forest Close
Sheffield, South Yorkshire, s35 0jw, United Kingdom
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2024
First Posted
June 26, 2024
Study Start
October 9, 2024
Primary Completion
April 30, 2025
Study Completion
May 24, 2025
Last Updated
March 13, 2026
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
Data may be made openly available through the data repository at the University of Sheffield depending on the data sharing agreement with the Sheffield health and social care (SHSC).